CVS Health CVS and The Cigna Group CI stand as two dominant forces in the U.S. diversified healthcare sector, commanding ...

Cigna will cap out-of-pocket costs at $200 per month for patients using the weight-loss drugs Wegovy and Zepbound through an ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

This was the stock's second consecutive day of losses.

UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390. Rice shared his views ...

Cigna Group’s drug benefit unit is offering a new way for health plans to cover expensive weight-loss drugs that it says will ...

Costco eyes 11.3% EPS growth in 2025, Chubb boosts income outlook, and Cigna posts strong Q1 as Zacks spotlights five standout stocks. On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

The focus of the lawsuit is forfeited funds, which total the amount of employer match contributions participants lose if they ...

U.S. prices for new drugs more than doubled last year compared to 2021, as companies developed more therapies for rare ...

The Cigna Group’s (NYSE:CI) strategic departure from the Medicare […] On Friday, May 23, UBS analyst AJ Rice reaffirmed a “Buy” rating on The Cigna Group (NYSE:CI) with a price target of $390.